Ebix Signs Agreement to Acquire Inward International

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
177
Ebix Signs Agreement to Acquire Inward International Remittance Business from Wall Street Finance Limited (BSE: WSFIN)

JOHNS CREEK, GA--(Marketwired - Aug 17, 2017) -  Ebix, Inc. ( NASDAQ : EBIX ), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, today announced that it has entered into an agreement to acquire Money Transfer Service Scheme (MTSS) Business of Wall Street Finance Limited ( BSE : WSFIN ) along with the acquisition of its subsidiary company Goldman Securities Limited, for $7.4 million. The agreement while approved by the Wall Street Board, is subject to its shareholders approval. The customary process for such approval can take a timeline of 45 to 75 days.

The acquisition once approved, is expected to be accretive to Ebix earnings immediately. The Company funded the transaction using its internal cash reserves.

The acquisition of these MTSS inward remittance assets, which control approximately 10% of the market, would further strengthen Ebix's position in the Financial Exchange market in India, following its acquisition of ItzCash in May 2017. Ebix's ItzCash service is the largest domestic remittance exchange in India with domestic remittance volume of approximately $100 million per month. The addition of this international capability significantly expands upon Ebix's overall participation in India's remittance channels, and will allow Ebix's financial exchange to remit money sent from abroad through Western Union, Ria or InstaCash.

The acquisition also brings Wall Street Finance's network of 10 Branches and over 9,000 sub-agents to Ebix, building upon its ItzCash exchange's distribution network of 75,000+ physical retail outlets. Ebix's ItzCash exchange is a recognized leader in prepaid cards, domestic remittances and bill payments, processing approximately 600,000 transactions per day and approximately $2 Billion in annual payment volume, with an industry leading transaction success rate of 99%.

Ebix's goal is to become India's largest Financial Exchange, with integrated offerings for insurance, healthcare and telemedicine. This acquisition advances this goal, providing the assets necessary to run an international remittance exchange business, while also enabling cross-selling opportunities for remittance services and a range of financial, insurance, and travel related services to each respective network.

Ebix Chairman, President and CEO Robin Raina, "We are focused on establishing Ebix as a leader in the Financial Exchange markets in India. This acquisition will not only expand our reach in the country, but will establish Ebix as a key player in the international remittance exchange markets. Over the next few months, our strategy in the space will become clearer to all concerned as we unveil a series of other steps to further grow our presence in the financial exchange markets."

Robin added, "The acquisition of these MTSS assets will complement our ItzCash financial exchange and allow us to streamline costs further while offering tremendous cross selling opportunities. This should also help enhance our operating margins, in the financial exchange segment in India."

About Ebix, Inc.

A leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, Ebix, Inc. provides end-to-end on-Demand solutions ranging from infrastructure exchanges, front end & back end enterprise systems, outsourced administrative & custom software development solutions, and risk compliance solutions for various entities involved in these industries.

With 40+ offices across Australia, Brazil, Canada, India, New Zealand, Singapore, the US and the UK, Ebix powers multiple exchanges across the world in the field of life, annuity, health and property & casualty insurance while conducting in excess of $100 billion in insurance premiums annually on its platforms. Through its various SaaS-based software platforms, Ebix employs hundreds of domain specific business and technology professionals to provide products, support and consultancy to thousands of customers on six continents. For more information, visit the Company's website at www.ebix.com

About Wall Street Finance Limited

Wall Street Finance Limited is listed on the BSE ( BSE : WSFIN ). It is engaged in the business of international inward remittance under the MTSS license from RBI and the foreign exchange and international outward remittance business under the AD2 license from RBI. With a market share of around 10 percent of the international inward remittance markets, Wall Street has a vast network of 10 MTSS Branches and over 9,000 sub-agents across India. Along with its subsidiary, this financial exchange serves to remit money sent through Western Union, Ria, Xpress Money and Instant Cash to be handed over to consumers through its distribution network spanning all across the country. For more information, visit the Company's website at http://www.wallstreetfinanceltd.com/receive-money

About ItzCash

An Ebix Group Company now, ItzCash Card Ltd., India's leading Digital Payments fintech was established in 2006. A pioneer in the prepaid payments in India, ItzCash initiated the concept of 'digital cash' to the Indian consumer and various business entities, heralding the beginning towards enabling a cashless transacting society. ItzCash continues to build on its innovation augmenting its product portfolio offering wide choice of payments and money transfer service having issued 110 million accounts to date. It constantly invests in upgrading technology towards creating world‐class Omni-channel payments platforms for the emerging India. ItzCash has presence across consumer segments serving 35 million consumers annually and over 75,000 franchisees branded as "ItzCash World" in 3000+ cities and towns. For further details, visit www.itzcash.com

SAFE HARBOR REGARDING FORWARD-LOOKING STATEMENTS

As used herein, the terms "Ebix," "the Company," "we," "our" and "us" refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.

The information contained in this Press Release contains forward-looking statements and information within the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company's products by the market, and management's plans and objectives. In addition, certain statements included in this and our future filings with the Securities and Exchange Commission ("SEC"), in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "seeks," "plan," "project," "continue," "predict," "will," "should," and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference, include, but are not limited to those discussed in our Annual Report on Form 10-K and subsequent reports filed with the SEC, as well as: the risk of an unfavorable outcome of the pending governmental investigations or shareholder class action lawsuits, reputational harm caused by such investigations and lawsuits, the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company's ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia, UK and India wherein we have significant operations); equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts.

Except as expressly required by the federal securities laws, the Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.

Readers should carefully review the disclosures and the risk factors described in the documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto. You may obtain our SEC filings at our website, www.ebix.com under the "Investor Information" section, or over the Internet at the SEC's web site, www.sec.gov .

CONTACT: Darren Joseph 678 -281-2027 Email Contact David Collins or Chris Eddy Catalyst Global 212-924-9800 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 116

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 350

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 63

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 554

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 356

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 270

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Large-Cap Stocks to Watch for Future Growth Opportunities

Updated Category News Views 409

Emerging Large-Cap Stocks: Evaluating Performance Last week proved to be a robust period for several large-cap stocks, demonstrating significant gains on the market. If you're looking to expand your portfolio with top performers, it's essential to keep an eye on these standout companies. AeroVironment's Spectacular Performance AeroVironment, Inc. (NASDAQ: AVAV) saw its...

Continue Reading
Celebrating 80 Years of Unity: Manchester Congress Reimagined

Updated Category News Views 373

Celebrating the Legacy of the Manchester Congress The Pan-African Progressive Front (PPF), working hand in hand with various organizations, has embarked on an exciting journey to commemorate the 80th anniversary of the historic Manchester Congress. This momentous event, pivotal in shaping pan-African unity and liberation movements, is set to stir conversations and inspire...

Continue Reading
Stifel Optimistic on Nurix's NX-5948 Ahead of ASH Presentation

Updated Category News Views 86

Stifel's Positive Adjustment for Nurix Therapeutics Stock Stifel, a well-known financial services firm, has shown renewed confidence in Nurix Therapeutics Inc. (NASDAQ: NRIX) by increasing its price target for the company’s shares from $30 to $34 while keeping a Buy rating. This optimistic outlook reflects anticipation surrounding Nurix's ongoing drug trials,...

Continue Reading
Josh Christie Steps Up as Chief Managing Partner at Ice Miller

Updated Category News Views 266

Josh Christie Steps Up as Chief Managing Partner at Ice Miller Ice Miller is excited to share that Joshua Christie will serve as its new Chief Managing Partner starting January 1, 2026. His election reflects the firm’s trust in his leadership capabilities and vision for the future. Based in the Indianapolis office, Christie has been an integral part of Ice Miller since...

Continue Reading
IPSEN's Latest Buy-Back Initiative: Weekly Summary Insights

Updated Category News Views 156

IPSEN's Buy-Back Program Overview IPSEN has embarked on an exciting buy-back program aimed at enhancing shareholder value by strategically purchasing its own shares. This initiative is not only an investment in its financial health but also reflects the confidence IPSEN has in its future. As of Week 33, 2025, a comprehensive overview of the transactions executed...

Continue Reading